Janus kinase (JAK) inhibitors, biologics and more—Dr. Laura Coates discussed the management of PsA, providing insights into the current research and when clinicians may want to consider prescribing specific medications.
FDA Approves Ustekinumab-stba for All Forms & Dosages as Its Reference Product
Ustekinumab-stba (Steqeyma) now has FDA approval for all forms and dosages of its reference product, ustekinumab (Stelara), including a subcutaneous injection to treat pediatric patients with plaque psoriasis or psoriatic arthritis.
Rheum for Everyone, Superheroes, Secret Identities & You: Episode 22 (video)
In this episode, Dr. Kumar talks about the fascinating and intriguing secret lives of rheumatologists—real life superheroes.
B Original
Experts discussed how aspects of the immune system other than B cells play a role in lupus, including mitochondria in red blood cells, proteins present in urine and more.
Physician Editor Bharat Kumar, MD, & The Rheumatologist Recognized for Excellence
The American College of Rheumatology and Wiley are happy to announce that The Rheumatologist has received two APEX Awards of Excellence this year for content published in 2024. Rheuminations, the monthly editorial written by Physician Editor Bharat Kumar, MD, MME, FACP, FAAAAI, RhMSUS, was honored with an Award of Excellence for Writing, Regular Departments &…
Douglas White, MD, PhD, Transitions to Private Practice
ACR Past President Douglas White, MD, PhD, discusses his transition to private practice & the tensions between private practice & academic rheumatologists.
Rheumatology Influencers: Dr. Christopher Morris’ Approach to Leadership
Dr. Christopher Morris discusses his approach to training the next generation of rheumatologists to account for disparities in access to rheumatic care& the value of multidisciplinary medical organizations.
Highlights from the European Congress of Internal Medicine
An overview of highlights from the 2025 ECIM meeting, including research on treatment options for systemic sclerosis, the management of PMR & autoimmune testing.
New Study: Upadacitinib Is Treatment Option for Giant Cell Arteritis
Results of the international SELECT-GCA study suggest that upadacitinib may be an effective new oral treatment for giant cell arteritis.
Reflections on the Choose Rheumatology Experience
A third-year internal medicine resident describes the impact of attending ACR Convergence & the benefits of participating in the Choose Rheumatology Experience hosted by the Rheumatology Research Foundation.
- 1
- 2
- 3
- …
- 823
- Next Page »